Kasabach-Merritt syndrome overview

Jump to navigation Jump to search

Kasabach-Merritt syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Kasabach-Merritt syndrome from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Kasabach-Merritt syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kasabach-Merritt syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kasabach-Merritt syndrome overview

CDC on Kasabach-Merritt syndrome overview

Kasabach-Merritt syndrome overview in the news

Blogs on Kasabach-Merritt syndrome overview

Directions to Hospitals Treating Kasabach-Merritt syndrome

Risk calculators and risk factors for Kasabach-Merritt syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Kasabach-Merritt Syndrome (KMS) is a rare disease, usually of infants, in which a vascular tumor leads to decreased platelet counts and sometimes other bleeding problems,[1] which can be life-threatening.[2] It is also known as hemangioma thrombocytopenia syndrome.

References

  1. Hall G (2001). "Kasabach-Merritt syndrome: pathogenesis and management". Br J Haematol. 112 (4): 851–62. PMID 11298580.
  2. Shim W (1968). "Hemangiomas of infancy complicated by thrombocytopenia". Am J Surg. 116 (6): 896–906. PMID 4881491.

Template:WH Template:WS